Trials / Unknown
UnknownNCT05830019
Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (estimated)
- Sponsor
- Shanghai Proton and Heavy Ion Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the toxicity and tolerance of carbon ion radiotherapy for recurrent pancreatic carcinoma post surgery
Detailed description
The carbon dose of 67.5 Gy equivalent in 15 fractions was delivered to clinical target volume (CTV). The dose limiting toxicity (DLT) was defined as CTCAE grade 3 or higher of non-hematological toxicity (G3). The acute and late toxicities, overall survival (OS), progression-free survival (PFS), local progression-free survival (LPFS) and distant metastasis-free survival (DMFS) were the endpoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | carbon ion radiotherapy | carbon ion radiotherapy |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2023-04-26
- Last updated
- 2023-04-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05830019. Inclusion in this directory is not an endorsement.